Neogen Corporation (NEOG) Stock Competitors & Peer Comparison
See (NEOG) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NEOG | $8.73 | -2.13% | 1.9B | -3.12 | -$2.80 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.77% |
| TMO | $471.12 | -4.64% | 179.2B | 26.53 | $18.17 | +0.37% |
| DHR | $176.11 | -2.09% | 124.6B | 34.13 | $5.16 | +0.77% |
| IDXX | $549.32 | -3.08% | 43.5B | 40.56 | $13.58 | N/A |
| A | $134.24 | -1.28% | 38.2B | 27.17 | $4.97 | +0.56% |
| NTRA | $209.29 | -4.35% | 30.5B | -130.47 | -$1.63 | N/A |
| IQV | $177.45 | -5.02% | 30.1B | 22.44 | $8.05 | N/A |
| ILMN | $162.89 | -0.92% | 24.6B | 29.52 | $5.51 | N/A |
| WAT | $369.47 | -2.30% | 24.2B | 47.30 | $7.86 | N/A |
Stock Comparison
NEOG vs DHR-PB Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, NEOG is priced at $8.73, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, NEOG's ROE is -0.29%, compared to DHR-PB's ROE of +0.07%. Regarding short-term risk, NEOG is less volatile compared to DHR-PB. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check DHR-PB's competition here
NEOG vs TMO Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, TMO has a market cap of 179.2B. Regarding current trading prices, NEOG is priced at $8.73, while TMO trades at $471.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas TMO's P/E ratio is 26.53. In terms of profitability, NEOG's ROE is -0.29%, compared to TMO's ROE of +0.13%. Regarding short-term risk, NEOG is less volatile compared to TMO. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check TMO's competition here
NEOG vs DHR Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, DHR has a market cap of 124.6B. Regarding current trading prices, NEOG is priced at $8.73, while DHR trades at $176.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas DHR's P/E ratio is 34.13. In terms of profitability, NEOG's ROE is -0.29%, compared to DHR's ROE of +0.07%. Regarding short-term risk, NEOG is less volatile compared to DHR. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check DHR's competition here
NEOG vs IDXX Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, IDXX has a market cap of 43.5B. Regarding current trading prices, NEOG is priced at $8.73, while IDXX trades at $549.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas IDXX's P/E ratio is 40.56. In terms of profitability, NEOG's ROE is -0.29%, compared to IDXX's ROE of +0.71%. Regarding short-term risk, NEOG is less volatile compared to IDXX. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check IDXX's competition here
NEOG vs A Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, A has a market cap of 38.2B. Regarding current trading prices, NEOG is priced at $8.73, while A trades at $134.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas A's P/E ratio is 27.17. In terms of profitability, NEOG's ROE is -0.29%, compared to A's ROE of +0.21%. Regarding short-term risk, NEOG is less volatile compared to A. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check A's competition here
NEOG vs NTRA Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, NTRA has a market cap of 30.5B. Regarding current trading prices, NEOG is priced at $8.73, while NTRA trades at $209.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas NTRA's P/E ratio is -130.47. In terms of profitability, NEOG's ROE is -0.29%, compared to NTRA's ROE of -0.15%. Regarding short-term risk, NEOG and NTRA have similar daily volatility (0.00).Check NTRA's competition here
NEOG vs IQV Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, IQV has a market cap of 30.1B. Regarding current trading prices, NEOG is priced at $8.73, while IQV trades at $177.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas IQV's P/E ratio is 22.44. In terms of profitability, NEOG's ROE is -0.29%, compared to IQV's ROE of +0.22%. Regarding short-term risk, NEOG and IQV have similar daily volatility (0.00).Check IQV's competition here
NEOG vs ILMN Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, ILMN has a market cap of 24.6B. Regarding current trading prices, NEOG is priced at $8.73, while ILMN trades at $162.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas ILMN's P/E ratio is 29.52. In terms of profitability, NEOG's ROE is -0.29%, compared to ILMN's ROE of +0.34%. Regarding short-term risk, NEOG is less volatile compared to ILMN. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check ILMN's competition here
NEOG vs WAT Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, WAT has a market cap of 24.2B. Regarding current trading prices, NEOG is priced at $8.73, while WAT trades at $369.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas WAT's P/E ratio is 47.30. In terms of profitability, NEOG's ROE is -0.29%, compared to WAT's ROE of +0.08%. Regarding short-term risk, NEOG is less volatile compared to WAT. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check WAT's competition here
NEOG vs MTD Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, MTD has a market cap of 23.6B. Regarding current trading prices, NEOG is priced at $8.73, while MTD trades at $1,184.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas MTD's P/E ratio is 27.46. In terms of profitability, NEOG's ROE is -0.29%, compared to MTD's ROE of -6.10%. Regarding short-term risk, NEOG and MTD have similar daily volatility (0.00).Check MTD's competition here
NEOG vs DGX Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, DGX has a market cap of 21.4B. Regarding current trading prices, NEOG is priced at $8.73, while DGX trades at $193.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas DGX's P/E ratio is 21.37. In terms of profitability, NEOG's ROE is -0.29%, compared to DGX's ROE of +0.14%. Regarding short-term risk, NEOG is less volatile compared to DGX. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check DGX's competition here
NEOG vs LH Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, LH has a market cap of 21.1B. Regarding current trading prices, NEOG is priced at $8.73, while LH trades at $257.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas LH's P/E ratio is 22.83. In terms of profitability, NEOG's ROE is -0.29%, compared to LH's ROE of +0.11%. Regarding short-term risk, NEOG is less volatile compared to LH. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check LH's competition here
NEOG vs EXAS Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, NEOG is priced at $8.73, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas EXAS's P/E ratio is -95.37. In terms of profitability, NEOG's ROE is -0.29%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, NEOG and EXAS have similar daily volatility (0.00).Check EXAS's competition here
NEOG vs GH Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, GH has a market cap of 17.3B. Regarding current trading prices, NEOG is priced at $8.73, while GH trades at $129.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas GH's P/E ratio is -38.29. In terms of profitability, NEOG's ROE is -0.29%, compared to GH's ROE of +1.84%. Regarding short-term risk, NEOG is less volatile compared to GH. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check GH's competition here
NEOG vs PKI Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, NEOG is priced at $8.73, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas PKI's P/E ratio is 41.45. In terms of profitability, NEOG's ROE is -0.29%, compared to PKI's ROE of +0.03%. Regarding short-term risk, NEOG is less volatile compared to PKI. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check PKI's competition here
NEOG vs MEDP Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, MEDP has a market cap of 12.7B. Regarding current trading prices, NEOG is priced at $8.73, while MEDP trades at $445.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas MEDP's P/E ratio is 28.06. In terms of profitability, NEOG's ROE is -0.29%, compared to MEDP's ROE of +1.21%. Regarding short-term risk, NEOG is less volatile compared to MEDP. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check MEDP's competition here
NEOG vs RVTY Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, RVTY has a market cap of 11.2B. Regarding current trading prices, NEOG is priced at $8.73, while RVTY trades at $99.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas RVTY's P/E ratio is 48.29. In terms of profitability, NEOG's ROE is -0.29%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, NEOG and RVTY have similar daily volatility (0.00).Check RVTY's competition here
NEOG vs ICLR Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, ICLR has a market cap of 10.5B. Regarding current trading prices, NEOG is priced at $8.73, while ICLR trades at $137.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas ICLR's P/E ratio is 47.43. In terms of profitability, NEOG's ROE is -0.29%, compared to ICLR's ROE of +0.02%. Regarding short-term risk, NEOG is less volatile compared to ICLR. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check ICLR's competition here
NEOG vs CRL Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, CRL has a market cap of 8.4B. Regarding current trading prices, NEOG is priced at $8.73, while CRL trades at $173.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas CRL's P/E ratio is -47.21. In terms of profitability, NEOG's ROE is -0.29%, compared to CRL's ROE of -0.06%. Regarding short-term risk, NEOG is less volatile compared to CRL. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check CRL's competition here
NEOG vs QGEN Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, QGEN has a market cap of 7.4B. Regarding current trading prices, NEOG is priced at $8.73, while QGEN trades at $35.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas QGEN's P/E ratio is 18.20. In terms of profitability, NEOG's ROE is -0.29%, compared to QGEN's ROE of +0.11%. Regarding short-term risk, NEOG is less volatile compared to QGEN. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check QGEN's competition here
NEOG vs SYNH Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, NEOG is priced at $8.73, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas SYNH's P/E ratio is 61.40. In terms of profitability, NEOG's ROE is -0.29%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, NEOG is less volatile compared to SYNH. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check SYNH's competition here
NEOG vs TWST Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, TWST has a market cap of 4.4B. Regarding current trading prices, NEOG is priced at $8.73, while TWST trades at $69.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas TWST's P/E ratio is -53.22. In terms of profitability, NEOG's ROE is -0.29%, compared to TWST's ROE of -0.17%. Regarding short-term risk, NEOG and TWST have similar daily volatility (0.00).Check TWST's competition here
NEOG vs BLLN Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, BLLN has a market cap of 4.3B. Regarding current trading prices, NEOG is priced at $8.73, while BLLN trades at $93.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas BLLN's P/E ratio is 174.44. In terms of profitability, NEOG's ROE is -0.29%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, NEOG is less volatile compared to BLLN. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check BLLN's competition here
NEOG vs SHC Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, SHC has a market cap of 4.3B. Regarding current trading prices, NEOG is priced at $8.73, while SHC trades at $15.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas SHC's P/E ratio is 36.63. In terms of profitability, NEOG's ROE is -0.29%, compared to SHC's ROE of +0.21%. Regarding short-term risk, NEOG is less volatile compared to SHC. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check SHC's competition here
NEOG vs RDNT Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, RDNT has a market cap of 4.3B. Regarding current trading prices, NEOG is priced at $8.73, while RDNT trades at $53.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas RDNT's P/E ratio is -319.47. In terms of profitability, NEOG's ROE is -0.29%, compared to RDNT's ROE of -0.01%. Regarding short-term risk, NEOG is less volatile compared to RDNT. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check RDNT's competition here
NEOG vs OLK Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, NEOG is priced at $8.73, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas OLK's P/E ratio is -96.59. In terms of profitability, NEOG's ROE is -0.29%, compared to OLK's ROE of -0.07%. Regarding short-term risk, NEOG is less volatile compared to OLK. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check OLK's competition here
NEOG vs GRAL Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, GRAL has a market cap of 2.6B. Regarding current trading prices, NEOG is priced at $8.73, while GRAL trades at $59.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas GRAL's P/E ratio is -5.82. In terms of profitability, NEOG's ROE is -0.29%, compared to GRAL's ROE of -0.16%. Regarding short-term risk, NEOG and GRAL have similar daily volatility (0.00).Check GRAL's competition here
NEOG vs CDNA Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, CDNA has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $8.73, while CDNA trades at $22.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas CDNA's P/E ratio is -137.94. In terms of profitability, NEOG's ROE is -0.29%, compared to CDNA's ROE of -0.03%. Regarding short-term risk, NEOG is less volatile compared to CDNA. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check CDNA's competition here
NEOG vs PSNL Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, PSNL has a market cap of 987.5M. Regarding current trading prices, NEOG is priced at $8.73, while PSNL trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas PSNL's P/E ratio is -10.90. In terms of profitability, NEOG's ROE is -0.29%, compared to PSNL's ROE of -0.44%. Regarding short-term risk, NEOG and PSNL have similar daily volatility (0.00).Check PSNL's competition here
NEOG vs CSTL Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, CSTL has a market cap of 596.3M. Regarding current trading prices, NEOG is priced at $8.73, while CSTL trades at $19.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas CSTL's P/E ratio is -46.81. In terms of profitability, NEOG's ROE is -0.29%, compared to CSTL's ROE of -0.03%. Regarding short-term risk, NEOG is less volatile compared to CSTL. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check CSTL's competition here
NEOG vs GRALV Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, NEOG is priced at $8.73, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas GRALV's P/E ratio is N/A. In terms of profitability, NEOG's ROE is -0.29%, compared to GRALV's ROE of N/A. Regarding short-term risk, NEOG is less volatile compared to GRALV. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check GRALV's competition here
NEOG vs FLGT Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, FLGT has a market cap of 531.1M. Regarding current trading prices, NEOG is priced at $8.73, while FLGT trades at $18.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas FLGT's P/E ratio is -7.79. In terms of profitability, NEOG's ROE is -0.29%, compared to FLGT's ROE of -0.07%. Regarding short-term risk, NEOG is less volatile compared to FLGT. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check FLGT's competition here
NEOG vs MYGN Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, MYGN has a market cap of 407.1M. Regarding current trading prices, NEOG is priced at $8.73, while MYGN trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas MYGN's P/E ratio is -1.00. In terms of profitability, NEOG's ROE is -0.29%, compared to MYGN's ROE of -1.09%. Regarding short-term risk, NEOG and MYGN have similar daily volatility (0.00).Check MYGN's competition here
NEOG vs CO Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, NEOG is priced at $8.73, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas CO's P/E ratio is 5.06. In terms of profitability, NEOG's ROE is -0.29%, compared to CO's ROE of +0.11%. Regarding short-term risk, NEOG is less volatile compared to CO. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check CO's competition here
NEOG vs PRE Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, PRE has a market cap of 356.5M. Regarding current trading prices, NEOG is priced at $8.73, while PRE trades at $20.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas PRE's P/E ratio is -8.52. In terms of profitability, NEOG's ROE is -0.29%, compared to PRE's ROE of -0.36%. Regarding short-term risk, NEOG is less volatile compared to PRE. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check PRE's competition here
NEOG vs FLDM Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, NEOG is priced at $8.73, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas FLDM's P/E ratio is -4.74. In terms of profitability, NEOG's ROE is -0.29%, compared to FLDM's ROE of +0.17%. Regarding short-term risk, NEOG is less volatile compared to FLDM. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check FLDM's competition here
NEOG vs NEO Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, NEO has a market cap of 263.5M. Regarding current trading prices, NEOG is priced at $8.73, while NEO trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas NEO's P/E ratio is -13.14. In terms of profitability, NEOG's ROE is -0.29%, compared to NEO's ROE of -0.12%. Regarding short-term risk, NEOG is less volatile compared to NEO. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check NEO's competition here
NEOG vs OPGN Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, OPGN has a market cap of 242.7M. Regarding current trading prices, NEOG is priced at $8.73, while OPGN trades at $23.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas OPGN's P/E ratio is 132.83. In terms of profitability, NEOG's ROE is -0.29%, compared to OPGN's ROE of +1.58%. Regarding short-term risk, NEOG and OPGN have similar daily volatility (0.00).Check OPGN's competition here
NEOG vs IMDX Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, IMDX has a market cap of 159.7M. Regarding current trading prices, NEOG is priced at $8.73, while IMDX trades at $5.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas IMDX's P/E ratio is -3.94. In terms of profitability, NEOG's ROE is -0.29%, compared to IMDX's ROE of +3.81%. Regarding short-term risk, NEOG and IMDX have similar daily volatility (0.00).Check IMDX's competition here
NEOG vs GTH Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, NEOG is priced at $8.73, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas GTH's P/E ratio is -1.11. In terms of profitability, NEOG's ROE is -0.29%, compared to GTH's ROE of -1.01%. Regarding short-term risk, NEOG is less volatile compared to GTH. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check GTH's competition here
NEOG vs BDSX Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, BDSX has a market cap of 124.9M. Regarding current trading prices, NEOG is priced at $8.73, while BDSX trades at $15.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas BDSX's P/E ratio is -3.87. In terms of profitability, NEOG's ROE is -0.29%, compared to BDSX's ROE of -21.01%. Regarding short-term risk, NEOG and BDSX have similar daily volatility (0.00).Check BDSX's competition here
NEOG vs XGN Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, XGN has a market cap of 116.5M. Regarding current trading prices, NEOG is priced at $8.73, while XGN trades at $4.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas XGN's P/E ratio is -5.36. In terms of profitability, NEOG's ROE is -0.29%, compared to XGN's ROE of -1.14%. Regarding short-term risk, NEOG and XGN have similar daily volatility (0.00).Check XGN's competition here
NEOG vs ATLN Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, ATLN has a market cap of 115.9M. Regarding current trading prices, NEOG is priced at $8.73, while ATLN trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas ATLN's P/E ratio is -1.35. In terms of profitability, NEOG's ROE is -0.29%, compared to ATLN's ROE of +2.74%. Regarding short-term risk, NEOG and ATLN have similar daily volatility (0.00).Check ATLN's competition here
NEOG vs GENE Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, NEOG is priced at $8.73, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas GENE's P/E ratio is -38.25. In terms of profitability, NEOG's ROE is -0.29%, compared to GENE's ROE of -1.85%. Regarding short-term risk, NEOG and GENE have similar daily volatility (0.00).Check GENE's competition here
NEOG vs STIM Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, STIM has a market cap of 108.6M. Regarding current trading prices, NEOG is priced at $8.73, while STIM trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas STIM's P/E ratio is -2.89. In terms of profitability, NEOG's ROE is -0.29%, compared to STIM's ROE of -1.65%. Regarding short-term risk, NEOG is less volatile compared to STIM. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check STIM's competition here
NEOG vs SERA Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, SERA has a market cap of 77.9M. Regarding current trading prices, NEOG is priced at $8.73, while SERA trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas SERA's P/E ratio is -3.19. In terms of profitability, NEOG's ROE is -0.29%, compared to SERA's ROE of -0.41%. Regarding short-term risk, NEOG and SERA have similar daily volatility (0.00).Check SERA's competition here
NEOG vs DRIO Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, DRIO has a market cap of 54.8M. Regarding current trading prices, NEOG is priced at $8.73, while DRIO trades at $7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas DRIO's P/E ratio is -0.88. In terms of profitability, NEOG's ROE is -0.29%, compared to DRIO's ROE of +0.93%. Regarding short-term risk, NEOG is less volatile compared to DRIO. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check DRIO's competition here
NEOG vs STRR Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, STRR has a market cap of 42.7M. Regarding current trading prices, NEOG is priced at $8.73, while STRR trades at $11.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas STRR's P/E ratio is -4.62. In terms of profitability, NEOG's ROE is -0.29%, compared to STRR's ROE of -0.14%. Regarding short-term risk, NEOG is less volatile compared to STRR. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check STRR's competition here
NEOG vs PRPO Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, PRPO has a market cap of 40.2M. Regarding current trading prices, NEOG is priced at $8.73, while PRPO trades at $22.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas PRPO's P/E ratio is -49.96. In terms of profitability, NEOG's ROE is -0.29%, compared to PRPO's ROE of -0.07%. Regarding short-term risk, NEOG and PRPO have similar daily volatility (0.00).Check PRPO's competition here
NEOG vs STRRP Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, STRRP has a market cap of 33.2M. Regarding current trading prices, NEOG is priced at $8.73, while STRRP trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas STRRP's P/E ratio is -4.90. In terms of profitability, NEOG's ROE is -0.29%, compared to STRRP's ROE of -0.14%. Regarding short-term risk, NEOG is less volatile compared to STRRP. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check STRRP's competition here
NEOG vs MDXH Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, MDXH has a market cap of 32.9M. Regarding current trading prices, NEOG is priced at $8.73, while MDXH trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas MDXH's P/E ratio is -0.99. In terms of profitability, NEOG's ROE is -0.29%, compared to MDXH's ROE of +4.03%. Regarding short-term risk, NEOG and MDXH have similar daily volatility (0.00).Check MDXH's competition here
NEOG vs QUCY Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, QUCY has a market cap of 31M. Regarding current trading prices, NEOG is priced at $8.73, while QUCY trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas QUCY's P/E ratio is -0.11. In terms of profitability, NEOG's ROE is -0.29%, compared to QUCY's ROE of -2.44%. Regarding short-term risk, NEOG is less volatile compared to QUCY. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check QUCY's competition here
NEOG vs AKU Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, NEOG is priced at $8.73, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas AKU's P/E ratio is -0.13. In terms of profitability, NEOG's ROE is -0.29%, compared to AKU's ROE of -5.32%. Regarding short-term risk, NEOG is less volatile compared to AKU. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check AKU's competition here
NEOG vs CEMI Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, NEOG is priced at $8.73, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas CEMI's P/E ratio is -0.63. In terms of profitability, NEOG's ROE is -0.29%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, NEOG and CEMI have similar daily volatility (0.00).Check CEMI's competition here
NEOG vs ENZ Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, NEOG is priced at $8.73, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas ENZ's P/E ratio is -2.85. In terms of profitability, NEOG's ROE is -0.29%, compared to ENZ's ROE of -0.10%. Regarding short-term risk, NEOG is less volatile compared to ENZ. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check ENZ's competition here
NEOG vs PMD Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, NEOG is priced at $8.73, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas PMD's P/E ratio is -5.24. In terms of profitability, NEOG's ROE is -0.29%, compared to PMD's ROE of -0.32%. Regarding short-term risk, NEOG and PMD have similar daily volatility (0.00).Check PMD's competition here
NEOG vs ME Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, NEOG is priced at $8.73, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas ME's P/E ratio is -0.03. In terms of profitability, NEOG's ROE is -0.29%, compared to ME's ROE of -7.71%. Regarding short-term risk, NEOG and ME have similar daily volatility (0.00).Check ME's competition here
NEOG vs MYNZ Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, NEOG is priced at $8.73, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, NEOG's ROE is -0.29%, compared to MYNZ's ROE of -10.25%. Regarding short-term risk, NEOG is less volatile compared to MYNZ. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check MYNZ's competition here
NEOG vs VNRX Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, VNRX has a market cap of 12.4M. Regarding current trading prices, NEOG is priced at $8.73, while VNRX trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas VNRX's P/E ratio is -0.54. In terms of profitability, NEOG's ROE is -0.29%, compared to VNRX's ROE of +0.74%. Regarding short-term risk, NEOG and VNRX have similar daily volatility (0.00).Check VNRX's competition here
NEOG vs CHEK Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, NEOG is priced at $8.73, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas CHEK's P/E ratio is -0.43. In terms of profitability, NEOG's ROE is -0.29%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, NEOG is less volatile compared to CHEK. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check CHEK's competition here
NEOG vs BNR Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, BNR has a market cap of 10.2M. Regarding current trading prices, NEOG is priced at $8.73, while BNR trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas BNR's P/E ratio is -12.52. In terms of profitability, NEOG's ROE is -0.29%, compared to BNR's ROE of -0.10%. Regarding short-term risk, NEOG and BNR have similar daily volatility (0.00).Check BNR's competition here
NEOG vs MBAI Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, MBAI has a market cap of 9.8M. Regarding current trading prices, NEOG is priced at $8.73, while MBAI trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas MBAI's P/E ratio is 2.53. In terms of profitability, NEOG's ROE is -0.29%, compared to MBAI's ROE of +4.17%. Regarding short-term risk, NEOG and MBAI have similar daily volatility (0.00).Check MBAI's competition here
NEOG vs CNTG Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, NEOG is priced at $8.73, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas CNTG's P/E ratio is -0.23. In terms of profitability, NEOG's ROE is -0.29%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, NEOG and CNTG have similar daily volatility (0.00).Check CNTG's competition here
NEOG vs NOTV Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, NOTV has a market cap of 9.1M. Regarding current trading prices, NEOG is priced at $8.73, while NOTV trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas NOTV's P/E ratio is -0.10. In terms of profitability, NEOG's ROE is -0.29%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, NEOG is less volatile compared to NOTV. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check NOTV's competition here
NEOG vs BIAF Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, BIAF has a market cap of 7.6M. Regarding current trading prices, NEOG is priced at $8.73, while BIAF trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas BIAF's P/E ratio is -0.36. In terms of profitability, NEOG's ROE is -0.29%, compared to BIAF's ROE of -3.59%. Regarding short-term risk, NEOG and BIAF have similar daily volatility (0.00).Check BIAF's competition here
NEOG vs TRIB Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, TRIB has a market cap of 7.6M. Regarding current trading prices, NEOG is priced at $8.73, while TRIB trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas TRIB's P/E ratio is -0.37. In terms of profitability, NEOG's ROE is -0.29%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, NEOG is less volatile compared to TRIB. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check TRIB's competition here
NEOG vs APDN Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, NEOG is priced at $8.73, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas APDN's P/E ratio is -0.10. In terms of profitability, NEOG's ROE is -0.29%, compared to APDN's ROE of -6.53%. Regarding short-term risk, NEOG is less volatile compared to APDN. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check APDN's competition here
NEOG vs NVTA Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, NEOG is priced at $8.73, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas NVTA's P/E ratio is -0.00. In terms of profitability, NEOG's ROE is -0.29%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, NEOG is less volatile compared to NVTA. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check NVTA's competition here
NEOG vs LMDX Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, NEOG is priced at $8.73, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas LMDX's P/E ratio is -0.01. In terms of profitability, NEOG's ROE is -0.29%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, NEOG is less volatile compared to LMDX. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check LMDX's competition here
NEOG vs LMDXW Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, NEOG is priced at $8.73, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, NEOG's ROE is -0.29%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, NEOG is less volatile compared to LMDXW. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check LMDXW's competition here
NEOG vs ADVB Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, ADVB has a market cap of 4.7M. Regarding current trading prices, NEOG is priced at $8.73, while ADVB trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas ADVB's P/E ratio is 1.08. In terms of profitability, NEOG's ROE is -0.29%, compared to ADVB's ROE of -0.65%. Regarding short-term risk, NEOG is less volatile compared to ADVB. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check ADVB's competition here
NEOG vs BGLC Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, BGLC has a market cap of 4.4M. Regarding current trading prices, NEOG is priced at $8.73, while BGLC trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas BGLC's P/E ratio is -1.46. In terms of profitability, NEOG's ROE is -0.29%, compared to BGLC's ROE of -0.37%. Regarding short-term risk, NEOG is less volatile compared to BGLC. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check BGLC's competition here
NEOG vs BNGO Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, BNGO has a market cap of 4.1M. Regarding current trading prices, NEOG is priced at $8.73, while BNGO trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas BNGO's P/E ratio is -0.28. In terms of profitability, NEOG's ROE is -0.29%, compared to BNGO's ROE of -0.71%. Regarding short-term risk, NEOG is less volatile compared to BNGO. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check BNGO's competition here
NEOG vs NDRA Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, NDRA has a market cap of 3.8M. Regarding current trading prices, NEOG is priced at $8.73, while NDRA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas NDRA's P/E ratio is -0.62. In terms of profitability, NEOG's ROE is -0.29%, compared to NDRA's ROE of -5.13%. Regarding short-term risk, NEOG is less volatile compared to NDRA. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check NDRA's competition here
NEOG vs DMTK Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, NEOG is priced at $8.73, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas DMTK's P/E ratio is -0.04. In terms of profitability, NEOG's ROE is -0.29%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, NEOG is less volatile compared to DMTK. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check DMTK's competition here
NEOG vs SQL Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, NEOG is priced at $8.73, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas SQL's P/E ratio is -0.40. In terms of profitability, NEOG's ROE is -0.29%, compared to SQL's ROE of +2.74%. Regarding short-term risk, NEOG is less volatile compared to SQL. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check SQL's competition here
NEOG vs AWH Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, NEOG is priced at $8.73, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas AWH's P/E ratio is -0.09. In terms of profitability, NEOG's ROE is -0.29%, compared to AWH's ROE of +2.03%. Regarding short-term risk, NEOG and AWH have similar daily volatility (0.00).Check AWH's competition here
NEOG vs INBS Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, INBS has a market cap of 1.6M. Regarding current trading prices, NEOG is priced at $8.73, while INBS trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas INBS's P/E ratio is -0.22. In terms of profitability, NEOG's ROE is -0.29%, compared to INBS's ROE of -1.74%. Regarding short-term risk, NEOG and INBS have similar daily volatility (0.00).Check INBS's competition here
NEOG vs HTGM Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, NEOG is priced at $8.73, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas HTGM's P/E ratio is -0.03. In terms of profitability, NEOG's ROE is -0.29%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, NEOG and HTGM have similar daily volatility (0.00).Check HTGM's competition here
NEOG vs BIAFW Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, BIAFW has a market cap of 894.9K. Regarding current trading prices, NEOG is priced at $8.73, while BIAFW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas BIAFW's P/E ratio is N/A. In terms of profitability, NEOG's ROE is -0.29%, compared to BIAFW's ROE of -3.59%. Regarding short-term risk, NEOG and BIAFW have similar daily volatility (0.00).Check BIAFW's competition here
NEOG vs BIOC Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, NEOG is priced at $8.73, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas BIOC's P/E ratio is -0.01. In terms of profitability, NEOG's ROE is -0.29%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, NEOG is less volatile compared to BIOC. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check BIOC's competition here
NEOG vs ISPC Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, ISPC has a market cap of 426.3K. Regarding current trading prices, NEOG is priced at $8.73, while ISPC trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas ISPC's P/E ratio is -0.01. In terms of profitability, NEOG's ROE is -0.29%, compared to ISPC's ROE of -5.85%. Regarding short-term risk, NEOG is less volatile compared to ISPC. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check ISPC's competition here
NEOG vs PRENW Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, PRENW has a market cap of 224.8K. Regarding current trading prices, NEOG is priced at $8.73, while PRENW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas PRENW's P/E ratio is N/A. In terms of profitability, NEOG's ROE is -0.29%, compared to PRENW's ROE of -0.36%. Regarding short-term risk, NEOG is less volatile compared to PRENW. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check PRENW's competition here
NEOG vs SQLLW Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, SQLLW has a market cap of 164.5K. Regarding current trading prices, NEOG is priced at $8.73, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas SQLLW's P/E ratio is -0.01. In terms of profitability, NEOG's ROE is -0.29%, compared to SQLLW's ROE of +2.74%. Regarding short-term risk, NEOG is less volatile compared to SQLLW. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check SQLLW's competition here
NEOG vs TTOO Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, TTOO has a market cap of 56.1K. Regarding current trading prices, NEOG is priced at $8.73, while TTOO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas TTOO's P/E ratio is -0.07. In terms of profitability, NEOG's ROE is -0.29%, compared to TTOO's ROE of +1.47%. Regarding short-term risk, NEOG and TTOO have similar daily volatility (0.00).Check TTOO's competition here
NEOG vs BNGOW Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, NEOG is priced at $8.73, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas BNGOW's P/E ratio is N/A. In terms of profitability, NEOG's ROE is -0.29%, compared to BNGOW's ROE of -0.71%. Regarding short-term risk, NEOG is less volatile compared to BNGOW. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check BNGOW's competition here
NEOG vs MEUSW Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, NEOG is priced at $8.73, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas MEUSW's P/E ratio is N/A. In terms of profitability, NEOG's ROE is -0.29%, compared to MEUSW's ROE of -7.71%. Regarding short-term risk, NEOG is less volatile compared to MEUSW. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check MEUSW's competition here
NEOG vs PRXL Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, PRXL has a market cap of 0. Regarding current trading prices, NEOG is priced at $8.73, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas PRXL's P/E ratio is N/A. In terms of profitability, NEOG's ROE is -0.29%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, NEOG is less volatile compared to PRXL. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check PRXL's competition here
NEOG vs OCDX Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, NEOG is priced at $8.73, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas OCDX's P/E ratio is -42.28. In terms of profitability, NEOG's ROE is -0.29%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, NEOG is less volatile compared to OCDX. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check OCDX's competition here
NEOG vs DHR-PA Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, NEOG is priced at $8.73, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, NEOG's ROE is -0.29%, compared to DHR-PA's ROE of +0.07%. Regarding short-term risk, NEOG is less volatile compared to DHR-PA. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check DHR-PA's competition here
NEOG vs CHEKZ Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, NEOG is priced at $8.73, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, NEOG's ROE is -0.29%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, NEOG is less volatile compared to CHEKZ. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check CHEKZ's competition here
NEOG vs NDRAW Comparison June 2026
NEOG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 1.9B. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, NEOG is priced at $8.73, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of -3.12, whereas NDRAW's P/E ratio is N/A. In terms of profitability, NEOG's ROE is -0.29%, compared to NDRAW's ROE of -5.13%. Regarding short-term risk, NEOG is less volatile compared to NDRAW. This indicates potentially lower risk in terms of short-term price fluctuations for NEOG.Check NDRAW's competition here